Radiopharmaceuticals
Research News and Information

Sunday, November 22, 2009

Assessment of liver graft function and regeneration by galactosyl-human serum albumin (99mTc-GSA) liver scintigraphy in adult living-donor liver transplantation.

14 Dec 2009 BACKGROUND: In adult living-donor liver transplantation (LDLT), the assessment of the graft functional reserve is very important. We evaluated the graft functional reserve by technetium-99m-diethylenetriaminepenta-acetic acid-galactosyl-human serum ... Read more...

Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro.

30 Oct 2009 Dopamine (DA) D2 receptor supersensitivity has been linked to an increase in the density of the D2 high-affinity state as measured in vitro. The two- affinity-state model of the D2 receptor predicts that the ex vivo specific binding of ... Read more...

Evaluation of N-benzyl-N-[11C]methyl-2- (7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide ([11C]DAC) as a novel translocator protein (18 kDa) radioligand in kainic acid-lesioned rat.

30 Oct 2009 The aim of this study was to evaluate N-benzyl-N-[11C]methyl-2-(7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide ([11C]DAC) as a new translocator protein (18 kDa) [TSPO, formerly known as the peripheral-type benzodiazepine receptor (PBR)] ... Read more...

Latest indexed articles for 'Radiopharmaceuticals'

These are the very latest articles for this heading:

• Assessment of liver graft function and regeneration by galactosyl-human serum albumin (99mTc-GSA) liver scintigraphy in adult living-donor liver transplantation. 14 Dec 2009
• Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro. 30 Oct 2009
• Evaluation of N-benzyl-N-[11C]methyl-2- (7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide ([11C]DAC) as a novel translocator protein (18 kDa) radioligand in kainic acid-lesioned rat. 30 Oct 2009
• Prognostic importance of standardized uptake value on F-18 fluorodeoxyglucose-positron emission tomography in biliary tract carcinoma. 30 Oct 2009
• Bone marrow involvement in Q fever--detection by fluorine-18-labelled fluorodeoxyglucose PET. 30 Oct 2009
• Evaluation of spirocyclic 3-(3-fluoropropyl)-2-benzofurans as sigma1 receptor ligands for neuroimaging with positron emission tomography. 6 Oct 2009
• [Diagnosis of fever of unknown origin (FUO). Positron emission tomography/computed tomography (PET-CT)] 4 Oct 2009
• (68)Ga-DOTA-TOC/NOC in bronchial carcinoids. 29 Sep 2009
• FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome. 29 Sep 2009
• Residual brain viability, evaluated by (99m)Tc-ECD SPECT, in patients with suspected brain death and with confounding clinical factors. 29 Sep 2009
• Evaluation of myocardial viability with thallium-201 infusion MPSPECT after oral glucose application in patients with chronic coronary artery disease. 29 Sep 2009
• Clinical significance of diffusely increased splenic uptake on FDG-PET. 29 Sep 2009
• Stroke incidentally identified using improved positron emission tomography for microglial activation. 29 Sep 2009
• In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand. 29 Sep 2009
• Adrenocortical tumor with two distinct elements revealed by combined (18)F-fluorodeoxyglucose positron emission tomography and (131)I nor-cholesterol scintigraphy. 29 Sep 2009
• Radioguided localization of nonpalpable breast cancer lesions: randomized comparison with wire localization in patients undergoing conservative surgery and sentinel node biopsy. 29 Sep 2009
• Pharmacokinetics of (99m)Tc-MAG3. 29 Sep 2009
• Intake risk and dose evaluation methods for workers in radiochemistry labs of a medical cyclotron facility. 29 Sep 2009
• [Positron emission tomography as a tool for early prediction of therapy outcome in soft tissue sarcoma] 14 Sep 2009
• The editor's roundtable: intracoronary hyperoxemic therapy in acute myocardial infarction. 13 Sep 2009

See a longer list of these articles.

Technical information about 'Radiopharmaceuticals'

Definition: Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161)

Registry Number: 0

Descriptor UI: D019275

Alternative terms: Radiopharmaceuticals;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.720.470.410.650;

History Note: 97

Technical Notes: pharmaceuticals as source of radiation in radiother & radioisotope scanning; D25-26 qualif